[1] Caly WR, Abreu RM, Bitelman B, et al. Clinical Features of Refractory Ascites in Outpatients[J]. Clinics (Sao Paulo), 2017, 72(7): 405-410.
[2] Planas R, Montoliu S, Balleste B, et al. Natural history of patients hospitalized for management of cirrhotic ascites[J]. Clin Gastroenterol Hepatol, 2006, 4(11): 1385-1394.
[3] 徐炜捷, 刘宝荣, 杨世达, et al. 肝硬化腹水患者临床特征及顽固性腹水预后的影响因素[J]. 中国肝脏病杂志(电子版), 2022, 14(02): 42-49.
[4] Leveen HH, Christoudias G, Ip M, et al. Peritoneo-venous shunting for ascites[J]. Ann Surg, 1974, 180(4): 580-591.
[5] Biecker E. Diagnosis and therapy of ascites in liver cirrhosis[J]. World J Gastroenterol, 2011, 17(10): 1237-1248.
[6] Wong F. Management of refractory ascites[J]. Clin Mol Hepatol, 2023, 29(1): 16-32.
[7] Bai M, Qi X S, Yang ZP, et al. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis[J]. World J Gastroenterol, 2014, 20(10): 2704-2714.
[8] Bureau C, Thabut D, Oberti F, et al. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites[J]. Gastroenterology, 2017, 152(1): 157-163.
[9] Rosemurgy AS, Zervos EE, Clark WC, et al. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial[J]. Ann Surg, 2004, 239(6): 883-889; discussion 9-91.
[10] Hariharan D, Wilkes EA, Aithal GP, et al. Spontaneous central venous thrombosis and shunt occlusion following peritoneovenous shunt placement for intractable ascites[J]. Ann R Coll Surg Engl, 2017, 99(5): e145-e147. |
